Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Diabetic Gastroparesis - Overview
Diabetic Gastroparesis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Diabetic Gastroparesis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Diabetic Gastroparesis - Companies Involved in Therapeutics Development
Atlantic Healthcare Plc
Bird Rock Bio Inc
CinRx Pharma LLC
Johnson & Johnson
Neurogastrx Inc
PTC Therapeutics Inc
Takeda Pharmaceutical Co Ltd
Vanda Pharmaceuticals Inc
Diabetic Gastroparesis - Drug Profiles
deudomperidone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
metopimazine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nimacimab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
prucalopride succite - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PTC-923 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
renzapride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tradipitant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
trazpiroben - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Diabetic Gastroparesis - Dormant Projects
Diabetic Gastroparesis - Discontinued Products
Diabetic Gastroparesis - Product Development Milestones
Featured News & Press Releases
Dec 03, 2018: Vanda announces positive phase II study results for Tradipitant in patients with gastroparesis
May 15, 2018: EndoLogic Announces FDA Accepts Cardiac Safety Trial for Renzapride in Patients with Gastroparesis
Aug 09, 2017: EndoLogic Announces Feedback from Positive FDA Meeting for Renzapride in Diabetic Gastroparesis
May 03, 2017: EndoLogic Announces Scheduling of pre-IND Meeting with FDA to Discuss Renzapride in Diabetic Gastroparesis
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Diabetic Gastroparesis, 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Diabetic Gastroparesis, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Diabetic Gastroparesis - Pipeline by Atlantic Healthcare Plc, 2021
Diabetic Gastroparesis - Pipeline by Bird Rock Bio Inc, 2021
Diabetic Gastroparesis - Pipeline by CinRx Pharma LLC, 2021
Diabetic Gastroparesis - Pipeline by Johnson & Johnson, 2021
Diabetic Gastroparesis - Pipeline by Neurogastrx Inc, 2021
Diabetic Gastroparesis - Pipeline by PTC Therapeutics Inc, 2021
Diabetic Gastroparesis - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
Diabetic Gastroparesis - Pipeline by Vanda Pharmaceuticals Inc, 2021
Diabetic Gastroparesis - Dormant Projects, 2021
Diabetic Gastroparesis - Discontinued Products, 2021